Hong Kong
· Delayed Price · Currency is HKD EC Healthcare Statistics
Total Valuation
EC Healthcare has a market cap or net worth of HKD 746.68 million. The enterprise value is 1.92 billion.
| Market Cap | 746.68M |
| Enterprise Value | 1.92B |
Important Dates
The next estimated earnings date is Thursday, June 26, 2025.
| Earnings Date | Jun 26, 2025 |
| Ex-Dividend Date | Dec 30, 2024 |
Share Statistics
EC Healthcare has 1.19 billion shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 1.19B |
| Shares Outstanding | 1.19B |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 61.90% |
| Owned by Institutions (%) | 8.98% |
| Float | 451.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.73 |
| PS Ratio | 0.18 |
| PB Ratio | 0.29 |
| P/TBV Ratio | 1.73 |
| P/FCF Ratio | 1.18 |
| P/OCF Ratio | 0.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.58, with an EV/FCF ratio of 3.04.
| EV / Earnings | -166.94 |
| EV / Sales | 0.46 |
| EV / EBITDA | 2.58 |
| EV / EBIT | 14.25 |
| EV / FCF | 3.04 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.59.
| Current Ratio | 1.08 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 2.03 |
| Debt / FCF | 2.38 |
| Interest Coverage | 1.20 |
Financial Efficiency
Return on equity (ROE) is 1.40% and return on invested capital (ROIC) is 2.07%.
| Return on Equity (ROE) | 1.40% |
| Return on Assets (ROA) | 1.49% |
| Return on Invested Capital (ROIC) | 2.07% |
| Return on Capital Employed (ROCE) | 3.36% |
| Revenue Per Employee | 1.45M |
| Profits Per Employee | -4,005 |
| Employee Count | 2,611 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 21.78 |
Taxes
In the past 12 months, EC Healthcare has paid 3.67 million in taxes.
| Income Tax | 3.67M |
| Effective Tax Rate | 9.60% |
Stock Price Statistics
The stock price has decreased by -55.94% in the last 52 weeks. The beta is 1.22, so EC Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -55.94% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 0.72 |
| Relative Strength Index (RSI) | 52.74 |
| Average Volume (20 Days) | 384,950 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EC Healthcare had revenue of HKD 4.15 billion and -11.50 million in losses. Loss per share was -0.01.
| Revenue | 4.15B |
| Gross Profit | 1.34B |
| Operating Income | 131.81M |
| Pretax Income | 38.23M |
| Net Income | -11.50M |
| EBITDA | 428.83M |
| EBIT | 131.81M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 866.42 million in cash and 1.51 billion in debt, giving a net cash position of -639.98 million or -0.54 per share.
| Cash & Cash Equivalents | 866.42M |
| Total Debt | 1.51B |
| Net Cash | -639.98M |
| Net Cash Per Share | -0.54 |
| Equity (Book Value) | 2.54B |
| Book Value Per Share | 1.70 |
| Working Capital | 130.17M |
Cash Flow
In the last 12 months, operating cash flow was 793.32 million and capital expenditures -161.22 million, giving a free cash flow of 632.09 million.
| Operating Cash Flow | 793.32M |
| Capital Expenditures | -161.22M |
| Free Cash Flow | 632.09M |
| FCF Per Share | 0.53 |
Margins
Gross margin is 32.38%, with operating and profit margins of 3.17% and -0.28%.
| Gross Margin | 32.38% |
| Operating Margin | 3.17% |
| Pretax Margin | 0.92% |
| Profit Margin | -0.28% |
| EBITDA Margin | 10.33% |
| EBIT Margin | 3.17% |
| FCF Margin | 15.22% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 3.08%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 3.08% |
| Dividend Growth (YoY) | -78.72% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | 3.06% |
| Earnings Yield | -1.54% |
| FCF Yield | 84.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EC Healthcare has an Altman Z-Score of 1.21 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 6 |